Skip to main content
Clinical Trials/NCT01421420
NCT01421420
Recruiting
Not Applicable

Arizona Alzheimer's Disease Core Center

University of Arizona1 site in 1 country900 target enrollmentJuly 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's Disease
Sponsor
University of Arizona
Enrollment
900
Locations
1
Primary Endpoint
Neuropsychological Test Scores
Status
Recruiting
Last Updated
10 years ago

Overview

Brief Summary

The main objective of this research project is to provide a comprehensive clinical database of patients with Alzheimer's disease (AD) and other forms of dementia, individuals with mild cognitive impairment (MCI), and age-matched normal controls. The study will also attempt to identify cognitively normal individuals at genetically defined risk for Alzheimer's disease through genetic screening.

All participants are seen annually. Autopsies to establish diagnoses in patients with dementia, patients with mild MCI, and cognitively normal elderly control subjects will also be conducted.

Detailed Description

All participants are seen annually. In addition to a detailed neurological examination, participants will receive a standardized battery of neuropsychological tests and will undergo genetic testing. The investigators will provide standardized periodic longitudinal assessment of the research participants. Autopsies to establish neurohistopathological diagnoses in clinically well-characterized patients with dementia, patients with mild MCI, and cognitively normal elderly control subjects will also be conducted.

Registry
clinicaltrials.gov
Start Date
July 2001
End Date
July 2025
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • For patients with MCI, or dementia, the presence of cognitive deficits including memory, language, and executive function.

Exclusion Criteria

  • Presence of non-neurological medical conditions interfering with cognition.

Outcomes

Primary Outcomes

Neuropsychological Test Scores

Time Frame: Up to 20 years

Cognitive function will be evaluated on a yearly basis using a battery of neuropsychological tests, which will then be scored and normed according to established guidelines.

Secondary Outcomes

  • Brain Tissue(From date of entry until date of death assessed up to 20 years)
  • Neurological Exam(Up to 20 Years)

Study Sites (1)

Loading locations...

Similar Trials